The LPP Indexes Baseline and Treatment-Related Changes in Anxiety Sensitivity
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Development of neurophysiological treatment targets has been an important way to validate and advance treatment implementations. Anxiety Sensitivity (AS), described as a fear of fear, is one of the most well-researched transdiagnostic risk factors for psychopathology and has been demonstrated to be associated with a number of different INT symptoms and disorders, making it an ideal intervention target for treatment of anxiety and mood pathology. Currently, there exists a gap in terms of understanding underlying neural mechanisms of AS and treatment-related change in AS. The current study sought to examine the impact of 2 brief computerized interventions on AS in order to assess the P300 and late positive potential (LPP) event-related potential (ERP) components as an index of both baseline and treatment change in the transdiagnostic anxiety sensitivity construct. Participants received one of the following, with a 1-month follow-up: an anxiety reduction intervention of cognitive anxiety sensitivity treatment (CAST) alone, a mood intervention of cognitive bias modification interpretation (CBM-I), a combined CAST and CBM-I intervention, or a repeated contact control group. Baseline AS was significantly related to baseline P3/LPP, such that higher P3/LPP amplitude (heightened emotional reactivity) is associated with higher AS at intake. Further, treatment-related reductions in AS were associated with higher baseline reactivity: greater AS reductions at month one were associated with higher P3/LPP activity. Heightened emotional response was predictive of better treatment outcomes. Analyses also showed evidence for different mechanisms associated with CAST and CBM-I groups. Specifically, the CAST group evidenced predictions of treatment outcome in parietal areas, where the CBM-I group evidenced predictions in frontal areas. The Combined group evidenced both frontal and parietal activations, consistent with combining the effects from the CAST and CBM-I groups. These findings suggest that the P3/LPP is an index of cognitive-affective processes underlying AS at baseline and has predictive ability in assessing AS treatment outcome in that our observed treatment types engage different neural mechanisms.